In this Phase I trial for subjects with advanced head \& neck cancer, breast cancer, soft tissue sarcoma or melanoma all subjects will receive open label X-PAC…

Advanced Solid Tumor Cancer

~Estimated

~$10 – $8,750

Immunolight, LLCNCT04389281

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Earlier detection of disease recurrence will enable greater treatment options and has strong potential to improve patient outcomes. This project is translation…

Healthy VolunteerProstate CancerHead and Neck Cancer+10 more

~Estimated

~$10 – $750

Washington University School of MedicineNCT04354064

Phase 1

Phase I Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

The goal of this clinical trial is to learn if investigational drug called SYS6043 works in adults with advanced or metastatic solid tumors that have spread or…

CancerSolid Tumor CancerAdvanced Metastatic Cancer+4 more

~Estimated

~$10 – $8,750

Conjupro Biotherapeutics, Inc.NCT07424547

← PreviousPage 2 of 2Next →